Author: Multibagger News

Private Astronauts Set for Historic First Private Spacewalk in SpaceX Capsule – Polaris Dawn Mission By Joey Roulette In a groundbreaking moment for commercial spaceflight, a group of private astronauts is poised to perform the first private spacewalk in orbit on Thursday from a SpaceX capsule. This milestone event will test a new line of spacesuits and push the boundaries of what is possible in space exploration. The crew, consisting of a billionaire entrepreneur, a retired military fighter pilot, and two SpaceX employees, has been orbiting Earth aboard SpaceX’s Crew Dragon since their successful launch from Florida on Tuesday for…

Insider at Genelux Corp (OTC:GNLX) Sells Shares Worth $196,608: What Does This Mean for Investors? In recent news, an insider at Genelux Corp, a pharmaceutical company, has sold a significant amount of company stock. The transactions took place over three days, with shares being sold at varying prices. The total value of the shares sold amounted to approximately $196,608. Despite these sales, the trust associated with the insider still holds a substantial number of Genelux Corp shares. This news could be of interest to investors as insider transactions can provide insights into how the company’s leadership views the stock’s value…

EU Consumer Complaint Targets Gaming Giants: Epic Games, EA, Roblox, and More Over Misleading In-Game Purchases By Foo Yun Chee BRUSSELS (Multibagger) – In a significant development for the gaming industry, prominent videogame companies including Epic Games, Electronic Arts (NASDAQ: EA), and Roblox are facing an EU consumer complaint for allegedly misleading gamers into making in-game purchases. Rising Concerns Over Gaming Addiction Among Children As concerns mount over the potential for children to develop gaming addictions, parents are increasingly vocal about their belief that videogame makers are intentionally designing products to encourage addictive behavior. The European Consumer Organisation’s (BEUC) Stand…

The Ultimate Guide to Investing in Asian Markets: Analysis of U.S. Market Reactions to Inflation Figures and Potential Rate Cuts As the world’s best investment manager and financial market journalist, I bring you an exclusive look at the day ahead in Asian markets. The recent see-saw reactions of the U.S. market to inflation figures have left investors on edge, trying to predict the Federal Reserve’s next move on interest rates. Despite the volatility, the S&P 500 and Nasdaq closed with healthy gains, the fear index dropped, and Treasury yields rebounded. The CPI data revealed mixed signals, with core inflation rising…

Former CIA Officer Sentenced to 10 Years for Spying for China In a shocking turn of events, a former CIA officer, Alexander Yuk Ching Ma, has been sentenced to 10 years in prison after pleading guilty to spying for China. This unprecedented case has sent shockwaves through the intelligence community and raised serious concerns about national security. This plea agreement, reached in May, involved Ma admitting to conspiring to gather and deliver national defense information to China. The U.S. Justice Department has called this a grave violation of trust and a threat to the safety and security of the United…

Choice Hotels CEO Sells Stock: What Does It Mean for Investors in 2024? Choice Hotels International Inc. (NYSE: CHH) President and CEO, Patrick Pacious, recently sold a significant portion of his stock in the company. According to the latest SEC filings dated September 10, 2024, Pacious sold 10,025 shares of common stock at prices ranging from $119.82 to $121.93, totaling approximately $1,206,756. The sales were part of a pre-arranged trading plan, with Pacious also acquiring 10,025 shares through employee stock options. Insiders’ transactions like these can provide insights into executives’ views on their company’s performance. While the reasons for Pacious’s…

OpenAI Eyes $150 Billion Valuation: What This Means for Investors and the AI Industry (Multibagger) – In a groundbreaking move, AI powerhouse OpenAI is currently in discussions to raise funds that would catapult its valuation to an eye-popping $150 billion, according to Bloomberg News. This development underscores OpenAI’s position as a leading force in the artificial intelligence sector, making it one of the world’s most valuable startups. Key Details of the Funding Round OpenAI, renowned for its viral chatbot ChatGPT, is aiming to raise $6.5 billion from investors. Additionally, it seeks to secure another $5 billion in debt through a…

ECB Set to Cut Interest Rates Again, Investors on Edge for Further Easing The European Central Bank is almost certain to cut interest rates again on Thursday, with inflation risks still simmering despite a stuttering euro zone economy. Investors will be closely watching for clues about further easing in the ECB’s statements. ECB President Christine Lagarde is expected to maintain the bank’s recent narrative that decisions are made meeting by meeting, based on incoming data. However, all meetings are considered “live”, leaving the door open for a potential cut in October. The debate among policymakers is centered on the speed…

Amazon’s Shopping Chatbot Rufus to Introduce Sponsored Ads Soon | Amazon Advertising Amazon’s Rufus chatbot, designed for shopping purposes, will soon feature sponsored ads, as announced in a changelog by Amazon. These ads will be tailored to users in the U.S. based on their search and conversational context, with Rufus potentially generating text to complement ad copy. This move aims to enhance brand and product discovery for customers interacting with Rufus. The introduction of ads in Rufus follows similar initiatives by Microsoft, which incorporated ads into their chatbot Copilot across various platforms. As AI development requires significant investment, it’s not…

Relmada Therapeutics CEO Makes Major Stock Purchases, Insider Confidence Soars Sergio Traversa, the CEO of Relmada Therapeutics Inc. (NASDAQ:), has recently bought $395,114 worth of the company’s common stock in a series of transactions. These purchases, made between September 9 and September 11, 2024, reflect Traversa’s strong belief in the pharmaceutical company’s future. On the first day, Traversa acquired 55,579 shares at an average price of $2.71 each. The following day, he bought 33,014 shares at an average of $2.75 per share. The spree concluded on September 11 with 51,407 shares purchased at an average price of $2.99. These transactions…